Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) is set to announce its earnings results before the market opens on Tuesday, February 20th. Analysts expect the company to announce earnings of $0.13 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Tactile Systems Technology Price Performance
NASDAQ TCMD opened at $15.60 on Tuesday. The company has a market cap of $366.60 million, a PE ratio of 14.44 and a beta of 1.20. Tactile Systems Technology has a 52 week low of $9.69 and a 52 week high of $26.11. The company has a quick ratio of 2.81, a current ratio of 3.33 and a debt-to-equity ratio of 0.24. The firm’s 50-day simple moving average is $14.29 and its two-hundred day simple moving average is $14.74.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of TCMD. PNC Financial Services Group Inc. increased its position in shares of Tactile Systems Technology by 219.5% in the first quarter. PNC Financial Services Group Inc. now owns 2,016 shares of the company’s stock worth $40,000 after purchasing an additional 1,385 shares during the last quarter. International Assets Investment Management LLC grew its position in Tactile Systems Technology by 1,330.0% during the fourth quarter. International Assets Investment Management LLC now owns 2,860 shares of the company’s stock valued at $41,000 after acquiring an additional 2,660 shares during the last quarter. Teachers Retirement System of The State of Kentucky bought a new position in Tactile Systems Technology during the third quarter valued at approximately $43,000. UBS Group AG grew its position in Tactile Systems Technology by 25.1% during the third quarter. UBS Group AG now owns 6,349 shares of the company’s stock valued at $50,000 after acquiring an additional 1,274 shares during the last quarter. Finally, Point72 Hong Kong Ltd bought a new position in Tactile Systems Technology during the second quarter valued at approximately $75,000. 85.97% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices for the treatment of underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, treatment, and share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest for the treatment of retained pulmonary secretions, such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
- Five stocks we like better than Tactile Systems Technology
- How Technical Indicators Can Help You Find Oversold Stocks
- 3 attractive stocks that insiders are buying
- Stock Average Calculator
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- What is an Earnings Surprise?
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.